Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer (Q43237571)
Jump to navigation
Jump to search
scientific article published on 27 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer |
scientific article published on 27 October 2009 |
Statements
1 reference
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer (English)
1 reference
Motoki Miyazawa
1 reference
Ryuji Ohsawa
1 reference
Takuya Tsunoda
1 reference
Seiko Hirono
1 reference
Manabu Kawai
1 reference
Masaji Tani
1 reference
Yusuke Nakamura
1 reference
Hiroki Yamaue
1 reference
27 October 2009
1 reference
1 reference
101
1 reference
2
1 reference
433-439
1 reference
Identifiers
1 reference
1 reference